Get the Stockscreener App
3.11
0.64%
-0.02
After Hours:
3.09
-0.02
-0.64%
Virax Biolabs Group Ltd stock is traded at $3.11, with a volume of 80,225.
It is down -0.64% in the last 24 hours and down -41.46% over the past month.
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
See More
Previous Close:
$3.13
Open:
$2.95
24h Volume:
80,225
Relative Volume:
0.07
Market Cap:
$2.48M
Revenue:
$3,000
Net Income/Loss:
$-5.65M
P/E Ratio:
-2.4838
EPS:
-1.2521
Net Cash Flow:
$-5.88M
1W Performance:
-4.60%
1M Performance:
-41.46%
6M Performance:
-70.47%
1Y Performance:
-85.36%
1-Day Range:
$2.84
$3.12
1-Week Range:
$2.57
$3.54
52-Week Range:
$2.50
$28.50
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
3.11 | 2.34M | 3,000 | -5.65M | -5.88M | -1.2521 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
Virax Biolabs Approves 1-for-25 Share Consolidation to Maintain Nasdaq Listing - TipRanks
Virax Biolabs (NASDAQ: VRAX) enacts 1-for-25 share consolidation to meet Nasdaq bid rule - Stock Titan
Virax Biolabs (VRAX) Implements 1-for-25 Share Consolidation to Sustain Nasdaq Listing - GuruFocus
Virax Biolabs announces 1-for-25 reverse stock split - Investing.com
Virax Biolabs announces 1-for-25 reverse stock split By Investing.com - Investing.com Australia
Virax Biolabs cuts shares 25-to-1 to try to keep Nasdaq listing - Stock Titan
Virax Biolabs Group Ltd (VRAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Virax Biolabs Group Ltd (VRAX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Virax Biolabs Group Ltd (VRAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Virax Biolabs Group Ltd (VRAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Virax Biolabs Group Ltd (VRAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Virax Biolabs Group Ltd (VRAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Virax Biolabs Group Ltd (VRAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Virax Biolabs Group Ltd (VRAX) Institutional Confidence - TradingKey
Virax Biolabs Group Ltd (VRAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
These stocks are moving in today's after hours session - ChartMill
Virax Biolabs Shareholders Approve Reverse Split and Amended Charter at June 12 Meeting - TipRanks
Virax Biolabs (VRAX) investors approve reverse split range and new charter - Stock Titan
Virax Biolabs Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
What's going on in today's after hours session - ChartMill
Stocks Under $1: NXXT, TOON, VRAX, AIM, SBFM on Breakout Watch - marketscreener.com
Virax Biolabs (VRAX) Shows Promising Data for Long COVID Test - GuruFocus
Virax Biolabs reports positive pilot data for long COVID blood test - grafa.com
Virax Biolabs Reports Strong Early Data for Long COVID Test and Prepares Larger Validation Study - TipRanks
VRAXVirax Biolabs Group Ltd Stock Price and Quote - Finviz
Virax Biolabs (NASDAQ: VRAX) reports positive ViraxImmune Long COVID data - Stock Titan
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes - Yahoo Finance
Virax Biolabs Stock Faces a Make-or-Break Nasdaq Vote After a Wild Week - Bez Kabli
Virax Biolabs Calls June 5 EGM to Approve Reverse Share Split and Charter Amendments - The Globe and Mail
Virax Biolabs (NASDAQ: VRAX) seeks 10–30 for 1 reverse split to meet Nasdaq bid rule - Stock Titan
BC-most active stocks - MSN
Stay updated with the stocks that are on the move in today's pre-market session. - ChartMill
Nasdaq most active stocks: - MSN
Which stocks are most active on Tuesday? - ChartMill
In today's session, these stocks are experiencing unusual volume. - ChartMill
Let's take a look at the stocks that are in motion in today's session. - ChartMill
Wondering what's happening in today's pre-market session? - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Nasdaq Down 200 Points; Brady Earnings Top Views - Sahm
Why Is Virax Biolabs (VRAX) Stock Trending Overnight? - Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
These stocks are moving in today's session - ChartMill
Virax Biolabs Group Limited Surges 83.8% on Heavy Trading Volume - Meyka
Monday's session: most active stocks - ChartMill
Let's have a look at the top gainers and losers in the middle of the day of today's session. - ChartMill
Virax Biolabs (VRAX) Surges 177% as Low-float Momentum Meets Extreme Short Interest - Moomoo
Virax Biolabs (VRAX) surges 177% as low-float momentum meets extreme short interest - Quiver Quantitative
Trending Stocks Today | Sunshine Biopharma Surges 568.77% - Moomoo
Which stocks are gapping on Monday? - ChartMill
Why Virax Biolabs Stock Is Jumping Before the Bell Today - TechStock²
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):